Alzheimer's disease: role of aging in pathogenesis - PubMed (original) (raw)
Review
Alzheimer's disease: role of aging in pathogenesis
Denham Harman. Ann N Y Acad Sci. 2002 Apr.
Abstract
Alzheimer's disease (AD) is characterized by intraneuronal fibrillary tangles, plaques, and cell loss. Brain lesions in both sporadic AD (SAD) and familial AD (FAD) are the same, and in the same distribution pattern, as those in individuals with Down syndrome (DS) and in smaller numbers in nondemented older individuals. Dementia onset is around 40 years for DS, 40-60 years for FAD, and usually over 60 years for SAD. The different categories of AD may be due to processes that augment to different degrees the innate cellular aging rate, that is, mitochondrial superoxide radical (SO) formation. Thus, they increase the rate of accumulation of AD lesions. This lowers the age of onset into the dementia ranges associated with DS, FAD, and SAD, and concomitantly shortens life spans. Faster aging lowers AD onset age by decreasing the onset age for neurofibrillary tangle formation and neuronal loss, and the age when brain intercellular H2O2 can activate microglial cells. The early AD onset in DS is attributed to a defective mitochondrial complex 1. The proteins associated with FAD and their normal counterparts undergo proteolytic processing in the endoplasmic reticulum (ER). The mutated compounds increase the ratio of betaA42 to betaA40 and likely also down-regulate the ER calcium (Ca2+) buffering activity. Decreases in ER Ca2+ content should increase the mitochondrial Ca2+ pool, thus enhancing SO formation. SAD may be due to increased SO formation caused by mutations in the approximately 1000 genes involved in mitochondrial biogenesis and function. The hypothesis suggests measures to prevent and treat.
Similar articles
- Alzheimer's disease pathogenesis: role of aging.
Harman D. Harman D. Ann N Y Acad Sci. 2006 May;1067:454-60. doi: 10.1196/annals.1354.065. Ann N Y Acad Sci. 2006. PMID: 16804026 Review. - Alzheimer's disease: A hypothesis on pathogenesis.
Harman D. Harman D. J Am Aging Assoc. 2000 Jul;23(3):147-61. doi: 10.1007/s11357-000-0017-6. J Am Aging Assoc. 2000. PMID: 23604855 Free PMC article. - Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.
Wegiel J, Flory M, Kuchna I, Nowicki K, Wegiel J, Ma SY, Zhong N, Bobrowicz TW, de Leon M, Lai F, Silverman WP, Wisniewski T. Wegiel J, et al. Acta Neuropathol Commun. 2022 Jan 4;10(1):2. doi: 10.1186/s40478-021-01300-9. Acta Neuropathol Commun. 2022. PMID: 34983655 Free PMC article. - Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
Murphy GM Jr, Eng LF, Ellis WG, Perry G, Meissner LC, Tinklenberg JR. Murphy GM Jr, et al. Brain Res. 1990 Dec 24;537(1-2):102-8. doi: 10.1016/0006-8993(90)90345-c. Brain Res. 1990. PMID: 1707726 - [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M, Kawakubo T, Mori R, Iwata N. Asai M, et al. Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Yakugaku Zasshi. 2017. PMID: 28674290 Review. Japanese.
Cited by
- Cyclitols: From Basic Understanding to Their Association with Neurodegeneration.
Derkaczew M, Martyniuk P, Osowski A, Wojtkiewicz J. Derkaczew M, et al. Nutrients. 2023 Apr 23;15(9):2029. doi: 10.3390/nu15092029. Nutrients. 2023. PMID: 37432155 Free PMC article. Review. - Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration.
Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A. Mehan S, et al. Degener Neurol Neuromuscul Dis. 2022 Mar 7;12:31-59. doi: 10.2147/DNND.S247153. eCollection 2022. Degener Neurol Neuromuscul Dis. 2022. PMID: 35300067 Free PMC article. Review. - Novel Effects of Rosa damascena Extract on Patients with Neurocognitive Disorder and Depression: A Clinical Trial Study.
Esfandiary E, Abdolali Z, Omranifard V, Ghanadian M, Bagherian-Sararoud R, Karimipour M, Mahaki B, Dabiri S. Esfandiary E, et al. Int J Prev Med. 2018 Jun 29;9:57. doi: 10.4103/ijpvm.IJPVM_199_17. eCollection 2018. Int J Prev Med. 2018. PMID: 30050668 Free PMC article. - Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.
Griñán-Ferré C, Corpas R, Puigoriol-Illamola D, Palomera-Ávalos V, Sanfeliu C, Pallàs M. Griñán-Ferré C, et al. J Alzheimers Dis. 2018;62(3):943-963. doi: 10.3233/JAD-170664. J Alzheimers Dis. 2018. PMID: 29562529 Free PMC article. Review. - Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia.
Wang Z, Zhang YH, Guo C, Gao HL, Zhong ML, Huang TT, Liu NN, Guo RF, Lan T, Zhang W, Wang ZY, Zhao P. Wang Z, et al. Front Aging Neurosci. 2018 Feb 27;10:9. doi: 10.3389/fnagi.2018.00009. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29535623 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous